[{"Assets_0_Q2_USD":"41967000000.0","CIK":"59478","CommonStockDividendsPerShareDeclared_1_Q2_USD":"0.74","CommonStockDividendsPerShareDeclared_2_Q2_USD":"0.74","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"1.56","EarningsPerShareBasic_2_Q2_USD":"3.16","EarningsPerShareDiluted_1_Q2_USD":"1.55","EarningsPerShareDiluted_2_Q2_USD":"3.15","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"282857000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"2877800000.0","NetIncomeLossConverted_1_Q2_USD":"1412000000.0","NetIncomeLossConverted_2_Q2_USD":"2868500000.0","OfficialName":"Eli Lilly and Company Common Stock","RevenuesConverted_1_Q2_USD":"5499400000.0","RevenuesConverted_2_Q2_USD":"11359200000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q2_USD":"4272000000.0","StockholdersEquity_0_Q2_USD":"4092900000.0","Ticker":"LLY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"910900000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"911600000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"907200000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"907700000.0","filed":"20200731","footnote":null,"form":"10-Q","fp":"Q2","fy":"2020.0","name":"ELI LILLY & CO","period":"20200630","qtrs":"2","uom":"USD"}]